Study to Demonstrate the Safety of WBR Administered at the Same Time as Intrathecal Liposomal Cytarabine (DepoCyte®) Versus Intrathecal Liposomal Cytarabine (DepoCyte®) Administered After WBR for the Treatment of Solid Tumour Neoplastic Meningitis in Patients With or Without Brain Metastasis.
Clinical trial NCT00854867 · COMPLETED
Trial details
- NCT number
- NCT00854867
- Sponsor
- Mundipharma Research Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2012-10-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.